{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:57:52Z","timestamp":1775804272159,"version":"3.50.1"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The study is aimed to retrospectively compare the efficacy, safety, and impact on serum inflammatory markers between oral celecoxib combined with flurbiprofen hydrogel patch and oral celecoxib alone in the treatment of lateral epicondylitis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort analysis was conducted on 64 patients diagnosed with lateral epicondylitis between January 2022 and December 2024. Patients were divided into two groups: the combined therapy group (oral celecoxib + topical flurbiprofen hydrogel patch, n = 32) and the single therapy group (oral celecoxib alone, n = 32). The primary outcome measures were Visual Analog Scale (VAS) scores and Patient-Rated Tennis Elbow Evaluation (PRTEE) scores measured at pre-treatment, 2 weeks, and 4 weeks of treatment. Secondary outcome measures included overall efficacy rate, effecting time, and 3-month recurrence rate. Serum inflammatory markers (tumor necrosis factor-alpha (TNF-\u03b1), interleukin-6 (IL-6), and C-reactive protein (CRP)) were measured and compared between the two groups at pre-treatment, 2 weeks, and 4 weeks. Adverse events were evaluated between two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pre-treatment characteristics were comparable between the two groups. Regarding clinical efficacy, at both 2 and 4 weeks post-treatment, the combined therapy group showed significantly lower VAS scores (2 weeks post-treatment: 3.9 \u00b1 1.4 vs. 5.0 \u00b1 1.5, P = 0.003; 4 weeks post-treatment: 2.2 \u00b1 1.1 vs. 3.6 \u00b1 1.3, P &amp;lt; 0.001) and PRTEE scores (2 weeks post-treatment: 37.8 \u00b1 10.5 vs. 46.3 \u00b1 12.1, P = 0.004; 4 weeks post-treatment: 21.0 \u00b1 9.8 vs. 31.4 \u00b1 10.9, P &amp;lt; 0.001) compared to the single therapy group. The combined therapy group also demonstrated a higher overall efficacy rate (81.3% vs. 59.4%, P = 0.049) and a faster effecting time (median: 4.0 days vs. 7.0 days, P = 0.003). Regarding inflammatory markers, at both 2 and 4 weeks post-treatment, serum levels of TNF-\u03b1, IL-6, and CRP in the combined therapy group were significantly reduced from pre-treatment. Specifically, at 4 weeks post-treatment, TNF-\u03b1 levels were significantly lower in the combined therapy group (12.3 \u00b1 3.5\u00a0pg\/mL vs. 16.8 \u00b1 4.1\u00a0pg\/mL, P &amp;lt; 0.001), as were IL-6 levels (8.1 \u00b1 2.9\u00a0pg\/mL vs. 11.7 \u00b1 3.3\u00a0pg\/mL, P &amp;lt; 0.001) and CRP levels (5.2 \u00b1 2.1\u00a0mg\/L vs. 8.0 \u00b1 2.8\u00a0mg\/L, P &amp;lt; 0.001). In terms of safety, there was no significant difference in the overall incidence of adverse events (21.9% vs. 12.5%, P = 0.327) and the 3-month recurrence rate (15.6% vs. 34.4%, P = 0.085) between two groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>For lateral epicondylitis, the combination of oral celecoxib and topical flurbiprofen hydrogel patch is superior to oral celecoxib alone in alleviating pain, improving function, and reducing systemic inflammation. The combined therapy also increases the overall efficacy rate, reduces the effecting time, without increasing systemic adverse events. The combined regimen represents an effective and safe treatment option to offer benefits for clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fphar.2026.1774834","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:02:25Z","timestamp":1775800945000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["A retrospective study comparing oral celecoxib combined with flurbiprofen hydrogel patch versus oral celecoxib therapy for lateral epicondylitis: real-world analysis of the anti-inflammatory and analgesic efficacy and safety"],"prefix":"10.3389","volume":"17","author":[{"given":"Jinying","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiqiang","family":"Zhuo","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongfeng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junjie","family":"Zheng","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinci","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofeng","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Chun","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Shanghai Sixth People\u2019s Hospital affiliated to Shanghai Jiao Tong University School of Medicine","place":["Shanghai, China"]},{"name":"Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Coinnovation Center of Neuroregeneration, Medical School, Nantong University","place":["Nantong, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Jinjiang Municipal Hospital (Shanghai Sixth People\u2019s Hospital Fujian)","place":["Jinjiang, Fujian, China"]},{"name":"Clinical Research Center for Orthopedic Trauma and Reconstruction of Fujian Province","place":["Jinjiang, Fujian, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1302\/0301-620X.95B9.29285","article-title":"Lateral epicondylitis: a review of pathology and management","author":"Ahmad","year":"2013","journal-title":"Bone Jt. J."},{"key":"B2","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00590-021-03181-z","article-title":"Lateral epicondylitis of the elbow: an up-to-date review of management","volume":"33","author":"Ahmed","year":"2023","journal-title":"Eur. J. Orthop. Surg. Traumatol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1016\/j.jse.2020.10.008","article-title":"Increased expression of macrophages and inflammatory cytokines at tendon origin in patients with chronic lateral epicondylitis","volume":"30","author":"Al-Dhafer","year":"2021","journal-title":"J. Shoulder Elb. Surg."},{"key":"B4","doi-asserted-by":"publisher","first-page":"109278","DOI":"10.1016\/j.mehy.2019.109278","article-title":"A potential factor in the pathophysiology of lateral epicondylitis: the long sarcomere length of the extensor carpi radialis brevis muscle and implications for physiotherapy","volume":"130","author":"Bazancir","year":"2019","journal-title":"Med. Hypotheses"},{"key":"B5","doi-asserted-by":"publisher","first-page":"8980","DOI":"10.3390\/ijms22168980","article-title":"A combination of celecoxib and glucosamine sulfate has anti-inflammatory and chondroprotective effects: results from an in vitro Study on human osteoarthritic chondrocytes","volume":"22","author":"Cheleschi","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1556661","DOI":"10.3389\/fphar.2025.1556661","article-title":"New use of an old drug: mechanism of oseltamivir phosphate inhibiting liver cancer through regulation of lipophagy via NEU1","volume":"16","author":"Chen","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B7","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S2255-4971(15)30121-X","article-title":"LATERAL EPICONDYLITIS OF THE ELBOW","volume":"47","author":"Cohen","year":"2015","journal-title":"Rev. Bras. Ortop."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.3390\/bioengineering12121337","article-title":"A 3D ColMA-Based tenogenic microenvironment unveils the behavior of Tendon Stem\/Progenitor cells (TSPCs) from tendinopathic surgical explants","volume":"12","author":"Cortella","year":"2025","journal-title":"Bioeng. (Basel)"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/j.jse.2019.05.020","article-title":"Iontophoresis in lateral epicondylitis: a randomized, double-blind clinical trial","volume":"28","author":"da Luz","year":"2019","journal-title":"J. Shoulder Elb. Surg."},{"key":"B10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13018-022-02990-0","article-title":"In vitro effect of triamcinolone and platelet-rich plasma on cytokine levels of elbow lateral epicondylitis-derived cells","volume":"17","author":"de Melo Viveiros","year":"2022","journal-title":"J. Orthop. Surg. Res."},{"key":"B11","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1136\/bjsports-2012-091513","article-title":"Evidence for the effectiveness of electrophysical modalities for treatment of medial and lateral epicondylitis: a systematic review","volume":"48","author":"Dingemanse","year":"2014","journal-title":"Br. J. Sports Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.12968\/hmed.2019.80.11.647","article-title":"Lateral epicondylitis: the condition and current management strategies","volume":"80","author":"Duncan","year":"2019","journal-title":"Br. J. Hosp. Med. (Lond)."},{"key":"B13","doi-asserted-by":"publisher","first-page":"459","DOI":"10.3390\/jpm15100459","article-title":"Oxygen-Ozone therapy in tendinopathy management: a comprehensive review","volume":"15","author":"Far\u00ec","year":"2025","journal-title":"J. Pers. Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"962380","DOI":"10.3389\/fbioe.2022.962380","article-title":"Mannose-decorated ginsenoside Rb1 albumin nanoparticles for targeted anti-inflammatory therapy","volume":"10","author":"Fu","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"CD003686","DOI":"10.1002\/14651858.CD003686","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow in adults","author":"Green","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"1537776","DOI":"10.3389\/fphar.2025.1537776","article-title":"A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance","volume":"16","author":"Hou","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1007\/s10787-024-01454-7","article-title":"Celecoxib attenuates hindlimb unloading-induced muscle atrophy via suppressing inflammation, oxidative stress and ER stress by inhibiting STAT3","volume":"32","author":"Ji","year":"2024","journal-title":"Inflammopharmacology"},{"key":"B18","doi-asserted-by":"publisher","first-page":"707","DOI":"10.31128\/AJGP-07-20-5519","article-title":"Lateral epicondylitis: current concepts","volume":"49","author":"Johns","year":"2020","journal-title":"Aust. J. Gen. Pract."},{"key":"B19","doi-asserted-by":"publisher","first-page":"439309","DOI":"10.1155\/2015\/439309","article-title":"New developments in the use of biologics and other modalities in the management of lateral epicondylitis","volume":"2015","author":"Kahlenberg","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"B20","doi-asserted-by":"publisher","first-page":"202","DOI":"10.13107\/jocr.2024.v14.i09.4780","article-title":"Lateral epicondylitis treated with platelet-rich plasma injection and corticosteroid injection","volume":"14","author":"Krishnan","year":"2024","journal-title":"J. Orthop. Case Rep."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1644289","DOI":"10.3389\/fimmu.2025.1644289","article-title":"Macrophage PTP1B regulates mitochondrial dynamics via the JAK2\/STAT3-OPA1 axis and activates the cGAS\/STING signaling pathway","volume":"16","author":"Lei","year":"2025","journal-title":"Front. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S241","DOI":"10.1016\/j.otsr.2019.09.004","article-title":"Management of lateral epicondylitis","volume":"105","author":"Lenoir","year":"2019","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"172939","DOI":"10.1016\/j.ejphar.2020.172939","article-title":"Nobiletin suppresses IL-21\/IL-21 receptor-mediated inflammatory response in MH7A fibroblast-like synoviocytes (FLS): an implication in rheumatoid arthritis","volume":"875","author":"Liu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1485380","DOI":"10.3389\/fphar.2024.1485380","article-title":"Clopidogrel combined with rivaroxaban in peripheral artery disease after revascularization","volume":"15","author":"Lu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"829966","DOI":"10.3389\/fphar.2022.829966","article-title":"Indole-3-Carbinol selectively prevents chronic stress-induced depression-but not anxiety-like behaviors via suppressing pro-inflammatory cytokine production and oxido-nitrosative stress in the brain","volume":"13","author":"Pan","year":"2022","journal-title":"Front. Pharmacol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"CD003686","DOI":"10.1002\/14651858.CD003686.pub2","article-title":"Non-steroidal anti-inflammatory drugs (NSAIDs) for treating lateral elbow pain in adults","volume":"2013","author":"Pattanittum","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"B27","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.mcna.2014.04.002","article-title":"Elbow tendinopathy","volume":"98","author":"Pitzer","year":"2014","journal-title":"Med. Clin. North Am."},{"key":"B28","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1007\/s00421-024-05565-5","article-title":"A single, maximal dose of celecoxib, ibuprofen, or flurbiprofen does not reduce the muscle signalling response to plyometric exercise in young healthy adults","volume":"124","author":"Roberts","year":"2024","journal-title":"Eur. J. Appl. Physiol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1539690","DOI":"10.3389\/fphar.2025.1539690","article-title":"Roles of retinoic acid-related orphan receptor \u03b1 in high glucose-induced cardiac fibroblasts proliferation","volume":"16","author":"San","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"2515690X251355017","DOI":"10.1177\/2515690X251355017","article-title":"Efficacy of dry needling combined with eccentric exercise versus oral and topical NSAID treatment in patients with tennis elbow: a randomized controlled trial","volume":"30","author":"S\u00e1nchez-Mil\u00e1","year":"2025","journal-title":"J. Evid. Based Integr. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1593909","DOI":"10.3389\/fresc.2025.1593909","article-title":"Efficacy of extracorporeal shock wave therapy and nutraceutical supplementation in the treatment of lateral epicondylitis: a randomized controlled trial","volume":"6","author":"Scaturro","year":"2025","journal-title":"Front. Rehabil. Sci."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.3390\/biom14121636","article-title":"Celecoxib combined with tocilizumab has anti-inflammatory effects and promotes the recovery of damaged cartilage via the Nrf2\/HO-1 pathway in vitro","volume":"14","author":"Shimasaki","year":"2024","journal-title":"Biomolecules"},{"key":"B33","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1021\/acs.jnatprod.1c00480","article-title":"Biotransformation of betulonic acid by the fungus Rhizopus arrhizus CGMCC 3.868 and antineuroinflammatory activity of the biotransformation products","volume":"84","author":"Song","year":"2021","journal-title":"J. Nat. Prod."},{"key":"B34","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10787-019-00683-5","article-title":"Human umbilical cord mesenchymal stem cells alleviate inflammatory bowel disease by inhibiting ERK phosphorylation in neutrophils","volume":"28","author":"Wang","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1549883","DOI":"10.3389\/fphar.2025.1549883","article-title":"Transdermal delivery of traditional Chinese medicine patch vs. NSAIDs patch for alleviating inflammation and relieving pain for early-stage knee osteoarthritis: a retrospective case control study","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1512968","DOI":"10.3389\/fphar.2025.1512968","article-title":"MLKL as an emerging machinery for modulating organelle dynamics: regulatory mechanisms, pathophysiological significance, and targeted therapeutics","volume":"16","author":"Wang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1056\/NEJMcp2216734","article-title":"Lateral epicondylitis","volume":"388","author":"Wolf","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1573611","DOI":"10.3389\/fphar.2025.1573611","article-title":"Exploring the impact of cuproptosis on prostate cancer prognosis via RNA methylation regulation based on single cell and bulk RNA sequencing data","volume":"16","author":"Wu","year":"2025","journal-title":"Front. Pharmacol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"10804","DOI":"10.3390\/ijms262110804","article-title":"Platelet-Rich plasma (PRP): molecular mechanisms, actions and clinical applications in human body","volume":"26","author":"Wu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1080\/13880209.2021.1876101","article-title":"Eucalyptol ameliorates early brain injury after subarachnoid haemorrhage via antioxidant and anti-inflammatory effects in a rat model","volume":"59","author":"Xu","year":"2021","journal-title":"Pharm. Biol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"115186","DOI":"10.1016\/j.bcp.2022.115186","article-title":"Celecoxib alleviates denervation-induced muscle atrophy by suppressing inflammation and oxidative stress and improving microcirculation","volume":"203","author":"Zhang","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1038\/s41598-024-53669-x","article-title":"Impact of lifestyle and clinical factors on the prognosis of tennis elbow","volume":"14","author":"Zhang","year":"2024","journal-title":"Sci. Rep."},{"key":"B43","doi-asserted-by":"publisher","first-page":"107660","DOI":"10.1016\/j.intimp.2021.107660","article-title":"Alpinetin exerts anti-inflammatory, anti-oxidative and anti-angiogenic effects through activating the Nrf2 pathway and inhibiting NLRP3 pathway in carbon tetrachloride-induced liver fibrosis","volume":"96","author":"Zhu","year":"2021","journal-title":"Int. Immunopharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1774834\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T06:02:29Z","timestamp":1775800949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1774834\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,10]]},"references-count":43,"alternative-id":["10.3389\/fphar.2026.1774834"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1774834","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,10]]},"article-number":"1774834"}}